|
US4690915A
(en)
|
1985-08-08 |
1987-09-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adoptive immunotherapy as a treatment modality in humans
|
|
US5217891A
(en)
|
1987-07-28 |
1993-06-08 |
Chiron Corporation |
DNA constructs containing a kluyveromyces α factor leader sequence for directing secretion of heterologous polypeptides
|
|
ATE127345T1
(de)
|
1988-06-15 |
1995-09-15 |
Whitehead Biomedical Inst |
Stressproteine und verwendungen dafür.
|
|
WO1990002564A1
(en)
|
1988-09-12 |
1990-03-22 |
Codon |
Vaccine diagnostic employing proteins homologous to heat shock proteins of trypanosoma cruzi
|
|
US5232833A
(en)
|
1988-09-14 |
1993-08-03 |
Stressgen Biotechnologies Corporation |
Accumulation of heat shock proteins for evaluating biological damage due to chronic exposure of an organism to sublethal levels of pollutants
|
|
EP0484440A4
(en)
|
1989-07-28 |
1993-01-07 |
Us Health |
Efficient directional genetic cloning system
|
|
GB9007194D0
(en)
|
1990-03-30 |
1990-05-30 |
Wellcome Found |
Live vaccines
|
|
US5348945A
(en)
|
1990-04-06 |
1994-09-20 |
Wake Forest University |
Method of treatment with hsp70
|
|
US5188964A
(en)
|
1990-04-12 |
1993-02-23 |
Board Of Regents, The University Of Texas System |
Method and kit for the prognostication of breast cancer patient via heat shock/stress protein determination
|
|
GB9016315D0
(en)
|
1990-07-25 |
1990-09-12 |
Burnie James P |
Medicaments
|
|
ATE154759T1
(de)
|
1990-11-08 |
1997-07-15 |
Univ London |
Mycobacterium als adjuvans für antigene
|
|
GB9024320D0
(en)
|
1990-11-08 |
1990-12-19 |
Univ London |
Treatment of uveitis
|
|
GB2251186A
(en)
|
1990-12-04 |
1992-07-01 |
Randall Neal Gatz |
Polypeptide for use in treatment of autoimmune disease
|
|
US5177942A
(en)
|
1991-08-15 |
1993-01-12 |
The Toro Company |
Mower deck with improved belt drive arrangement
|
|
GB9200949D0
(en)
|
1992-01-17 |
1992-03-11 |
Medical Res Council |
Diagnostic peptides
|
|
FR2688227A1
(fr)
|
1992-03-04 |
1993-09-10 |
Inst Nat Sante Rech Med |
Proteines formant des complexes avec des chaperones et leurs ligands, leurs fragments, leur obtention et leurs applications biologiques.
|
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
|
EP0630404A1
(en)
|
1992-03-09 |
1994-12-28 |
Istituto Nazionale Per Lo Studio E La Cura Dei Tumori Fondazione Giovanni Pascale |
Protein compound capable of inhibiting tumoral growth
|
|
CA2118015A1
(en)
|
1992-04-14 |
1993-10-28 |
Jeffrey R. Marks |
Method of detecting tumors containing complexes of p53 and hsp70
|
|
EP0745121B1
(en)
|
1992-05-14 |
2007-06-20 |
Baylor College Of Medicine |
Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy
|
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
|
WO1994003599A1
(fr)
|
1992-08-04 |
1994-02-17 |
Sagami Chemical Research Center |
ADNc HUMAIN ET PROTEINE POUR LAQUELLE CODE CET ADNc
|
|
GB2270076A
(en)
|
1992-08-18 |
1994-03-02 |
Univ Manchester |
Human HSP 90 Epitopes
|
|
GB9223816D0
(en)
|
1992-11-13 |
1993-01-06 |
Medical Res Council |
Heat shock proteins and the treatment of tumours
|
|
HUT73383A
(en)
|
1993-03-19 |
1996-07-29 |
Boehringer Sohn Ingelheim |
Process for preparing cancer vaccines
|
|
US5496934A
(en)
|
1993-04-14 |
1996-03-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nucleic acids encoding a cellulose binding domain
|
|
US6004941A
(en)
|
1993-06-14 |
1999-12-21 |
Basf Aktiengesellschaft |
Methods for regulating gene expression
|
|
WO1995004824A1
(en)
|
1993-08-05 |
1995-02-16 |
Medvet Science Pty. Ltd. |
Generation of dna libraries and retroviral vectors for same
|
|
US5705159A
(en)
|
1993-08-31 |
1998-01-06 |
John Wayne Cancer Institute |
Immunoreactive peptide sequence from a 43 KD human cancer antigen
|
|
US5750119A
(en)
|
1994-01-13 |
1998-05-12 |
Mount Sinai School Of Medicine Of The City University Of New York |
Immunotherapeutic stress protein-peptide complexes against cancer
|
|
US5997873A
(en)
|
1994-01-13 |
1999-12-07 |
Mount Sinai School Of Medicine Of The City University Of New York |
Method of preparation of heat shock protein 70-peptide complexes
|
|
US5961979A
(en)
|
1994-03-16 |
1999-10-05 |
Mount Sinai School Of Medicine Of The City University Of New York |
Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
|
|
WO1996001611A1
(en)
|
1994-07-08 |
1996-01-25 |
Baxter International Inc. |
Implanted device containing tumor cells for the treatment of cancer
|
|
US5772995A
(en)
|
1994-07-18 |
1998-06-30 |
Sidney Kimmel Cancer Center |
Compositions and methods for enhanced tumor cell immunity in vivo
|
|
DE69519521T2
(de)
|
1994-10-03 |
2001-06-28 |
The Government Of The United States Of America, As Represented By The Secretary National Institute Of Health |
Zusammensetzung enthaltend ein antigen exprimierendes rekombinantes virus und ein immunstimulierendes molekül exprimierendes rekombinantes virus
|
|
US5703057A
(en)
|
1995-04-07 |
1997-12-30 |
Board Of Regents The University Of Texas System |
Expression library immunization
|
|
US6331299B1
(en)
|
1995-08-18 |
2001-12-18 |
Sloan-Kettering Institute For Cancer Research |
Method for treatment of cancer and infectious disease and compositions useful in same
|
|
US6719974B1
(en)
|
1995-08-18 |
2004-04-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US6761892B1
(en)
|
1995-08-18 |
2004-07-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
IL123218A0
(en)
|
1995-08-18 |
1998-09-24 |
Sloan Kettering Inst Cancer |
Heat shock protein-based vaccines and immunotherapies
|
|
JPH11513369A
(ja)
|
1995-09-13 |
1999-11-16 |
フォーダム ユニバーシティー |
熱ショックタンパク質を用いる治療及び予防方法
|
|
US5935576A
(en)
|
1995-09-13 |
1999-08-10 |
Fordham University |
Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
|
|
US5985270A
(en)
|
1995-09-13 |
1999-11-16 |
Fordham University |
Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
|
|
US5837251A
(en)
|
1995-09-13 |
1998-11-17 |
Fordham University |
Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
|
|
DE19602985A1
(de)
|
1996-01-27 |
1997-07-31 |
Max Delbrueck Centrum |
Tumorzellimpfstoff für die Immuntheraphie von malignen Tumoren
|
|
WO1997026910A2
(de)
|
1996-01-27 |
1997-07-31 |
Max-Delbrück-Centrum für Molekulare Medizin |
Tumorimpfstoff für die immuntherapie von malignen tumoren
|
|
US5951976A
(en)
|
1996-03-28 |
1999-09-14 |
Whitenead Institute For Biomedical Research |
Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
|
|
US5747332A
(en)
|
1996-09-20 |
1998-05-05 |
University Of New Mexico |
Methods for purifying and synthesizing heat shock protein complexes
|
|
US6130087A
(en)
|
1996-10-07 |
2000-10-10 |
Fordham University |
Methods for generating cytotoxic T cells in vitro
|
|
JP4484969B2
(ja)
|
1996-11-26 |
2010-06-16 |
ヌベンタ バイオファーマスティカル コーポレイション |
ストレスタンパク質を含む組成物を使用する免疫応答
|
|
US6017540A
(en)
|
1997-02-07 |
2000-01-25 |
Fordham University |
Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
|
|
US5830464A
(en)
|
1997-02-07 |
1998-11-03 |
Fordham University |
Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
|
|
US6015709A
(en)
|
1997-08-26 |
2000-01-18 |
Ariad Pharmaceuticals, Inc. |
Transcriptional activators, and compositions and uses related thereto
|
|
US6007821A
(en)
|
1997-10-16 |
1999-12-28 |
Fordham University |
Method and compositions for the treatment of autoimmune disease using heat shock proteins
|
|
US5948646A
(en)
|
1997-12-11 |
1999-09-07 |
Fordham University |
Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
|
|
WO1999042121A1
(en)
|
1998-02-20 |
1999-08-26 |
University Of Miami |
Modified heat shock protein-antigenic peptide complex
|
|
US5989910A
(en)
|
1998-08-03 |
1999-11-23 |
University Of Lausanne |
Potent genetic switch allowing regulated gene expression in eukaryotic cells
|
|
US6797480B1
(en)
|
1998-10-05 |
2004-09-28 |
University Of Connecticut Health Center |
Purification of heat shock/stress protein cell surface receptors and their use as immunotherapeutic agents
|
|
US6451316B1
(en)
|
1998-10-05 |
2002-09-17 |
University Of Conneticut Health Center |
Methods for generating antigen-reactive T cells in vitro
|
|
US6475490B1
(en)
|
1998-10-19 |
2002-11-05 |
Fordham University |
Compositions and methods for promoting tissue repair using heat shock proteins
|
|
US6734172B2
(en)
*
|
1998-11-18 |
2004-05-11 |
Pacific Northwest Research Institute |
Surface receptor antigen vaccines
|
|
AU773954B2
(en)
*
|
1999-02-03 |
2004-06-10 |
Amgen, Inc. |
Novel Polypeptides involved in immune response
|
|
CN101070540B
(zh)
*
|
2000-04-28 |
2015-04-01 |
约翰霍普金斯大学 |
新的树突状细胞共刺激分子
|
|
US7132109B1
(en)
|
2000-10-20 |
2006-11-07 |
University Of Connecticut Health Center |
Using heat shock proteins to increase immune response
|
|
CA2452517A1
(en)
|
2001-07-11 |
2003-01-23 |
University Of Miami |
Recombinant vsv for the treatment of tumor cells
|
|
CN1635896A
(zh)
*
|
2001-08-20 |
2005-07-06 |
康涅狄格大学健康中心 |
包含用于治疗癌症及感染性疾病的热休克蛋白或α2－巨球蛋白的组合物制备方法
|
|
US7651686B2
(en)
*
|
2001-10-09 |
2010-01-26 |
Mayo Foundation For Medical Education And Research |
Enhancement of immune responses by 4-1bb-binding agents
|
|
EP1456376A4
(en)
|
2001-11-16 |
2006-09-06 |
Us Gov Health & Human Serv |
NEW CHIMERAL REV, TAT AND NEF ANTIGENES
|
|
WO2003057171A2
(en)
*
|
2002-01-03 |
2003-07-17 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of t-cells using an engineered multivalent signaling platform
|
|
CA2474954A1
(en)
|
2002-02-01 |
2003-08-07 |
Thomas Jefferson University |
Treatment of tumor cells for use in immunotherapy of cancer
|
|
CN1440812A
(zh)
*
|
2002-02-27 |
2003-09-10 |
上海中信国健药业有限公司 |
一种使用cd137结合激动剂增强免疫应答的方法
|
|
KR20040105736A
(ko)
*
|
2002-02-28 |
2004-12-16 |
안티제닉스 아이엔씨 |
스트레스 단백질의 올리고머화에 기초한 방법 및 산물
|
|
IL164376A0
(en)
*
|
2002-04-03 |
2005-12-18 |
Applied Research Systems |
Ox4or binding agents, their preparation and pharmaceutical compositions containing them
|
|
WO2003090686A2
(en)
*
|
2002-04-25 |
2003-11-06 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
US6984389B2
(en)
*
|
2002-04-25 |
2006-01-10 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
DE60317677T2
(de)
*
|
2002-06-13 |
2008-10-30 |
Crucell Holland B.V. |
Ox40 (=cd134) rezeptor agonisten und therapeutische verwendung
|
|
CN1756568A
(zh)
|
2002-10-09 |
2006-04-05 |
衣阿华中央卫生系统 |
使用表达α(1,3)－半乳糖基转移酶的同种异型肿瘤细胞的抗肿瘤免疫
|
|
US20040197312A1
(en)
*
|
2003-04-02 |
2004-10-07 |
Marina Moskalenko |
Cytokine-expressing cellular vaccine combinations
|
|
CA2538794C
(en)
*
|
2003-09-12 |
2016-04-19 |
Antigenics, Inc. |
Vaccine for treatment and prevention of herpes simplex virus infection
|
|
ES2333724T3
(es)
|
2003-09-26 |
2010-02-26 |
Merck Serono Sa |
Secuencias lideres para uso en la produccion de proteinas.
|
|
CA2540283C
(en)
|
2003-09-26 |
2019-05-21 |
University Of Miami |
Tumor vaccine
|
|
CA2548347A1
(en)
*
|
2003-12-11 |
2005-06-30 |
Sidney Kimmel Cancer Center |
Methods for generating immunity to antigen
|
|
FR2867982B1
(fr)
|
2004-03-26 |
2007-07-20 |
Jean Marie Andrieu |
Procede pour amplifier l'activite de vaccins therapeutiques
|
|
US7592313B2
(en)
*
|
2004-05-17 |
2009-09-22 |
Board Of Trustees Of The University Of Illinois |
Method of stimulating proliferation of regulatory T cells in a diabetic mammal
|
|
EP1856143A2
(en)
|
2005-02-24 |
2007-11-21 |
Medical Research Council |
Hivcon: anhiv immunogen and uses thereof
|
|
DK1877090T3
(da)
*
|
2005-05-06 |
2014-04-14 |
Providence Health System |
Trimert ox40-immunoglobulin-fusionsprotein og fremgangsmåder til anvendelse heraf
|
|
AU2006284922B2
(en)
*
|
2005-08-30 |
2012-01-19 |
University Of Miami |
Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists and immunotoxins
|
|
MX2008013993A
(es)
*
|
2006-05-03 |
2009-05-11 |
Univ Colorado |
Combinación adyuvante sinergistica de anticuerpo agonista de cd40/interferona tipo 1, conjugados que la contienen y uso de los mismos como un terapeutico para aumentar la inmunidad celular.
|
|
WO2008108808A2
(en)
*
|
2006-08-24 |
2008-09-12 |
Trustees Of Boston University |
Complexes derived from heterohybrid cells and uses thereof
|
|
SI2856876T1
(en)
*
|
2007-03-30 |
2018-04-30 |
Memorial Sloan-Kettering Cancer Center |
Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
|
|
ITPD20070252A1
(it)
*
|
2007-07-24 |
2009-01-25 |
Primiero Paolo |
Complessi di grp94 ed immunoglobuline g umane
|
|
US9408909B2
(en)
*
|
2007-09-14 |
2016-08-09 |
Vrije Universiteit Brussel |
Enhancing the T-cell stimulatory capacity of human antigen presenting cells in vitro and in vivo and its use in vaccination
|
|
GB0719509D0
(en)
*
|
2007-10-05 |
2007-11-14 |
Isis Innovation |
Molecular adjuvant
|
|
DK2257301T3
(da)
|
2008-03-03 |
2014-04-28 |
Univ Miami |
Immunterapi baseret på allogene cancerceller.
|
|
WO2009114110A1
(en)
|
2008-03-08 |
2009-09-17 |
Immungene, Inc. |
Engineered fusion molecules immunotherapy in cancer and inflammatory diseases
|
|
JP2011515399A
(ja)
*
|
2008-03-20 |
2011-05-19 |
ユニバーシティー オブ マイアミ |
熱ショックタンパクｇｐ９６ワクチン接種及びそれを用いた方法
|
|
US9931386B2
(en)
*
|
2008-06-16 |
2018-04-03 |
Atsuo Ochi |
Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity
|
|
AU2009316371B2
(en)
|
2008-11-21 |
2014-02-20 |
University Of Miami |
HIV/SIV vaccines for the generation of mucosal and systemic immunity
|
|
EP3255060A1
(en)
|
2008-12-09 |
2017-12-13 |
F. Hoffmann-La Roche AG |
Anti-pd-l1 antibodies and their use to enhance t-cell function
|
|
RU2011144575A
(ru)
*
|
2009-04-03 |
2013-05-10 |
Эйдженус Инк. |
Способы получения и применения мультишаперон-антигенных комплексов
|
|
CA2769822C
(en)
*
|
2009-08-13 |
2019-02-19 |
The Johns Hopkins University |
Methods of modulating immune function
|
|
US9459246B2
(en)
|
2009-09-08 |
2016-10-04 |
Nodality, Inc. |
Induced intercellular communication
|
|
EP2482849B1
(en)
*
|
2009-09-30 |
2018-06-06 |
Memorial Sloan-Kettering Cancer Center |
Combination immunotherapy for the treatment of cancer
|
|
WO2011069529A1
(en)
|
2009-12-09 |
2011-06-16 |
Curevac Gmbh |
Mannose-containing solution for lyophilization, transfection and/or injection of nucleic acids
|
|
KR20130010121A
(ko)
*
|
2010-03-23 |
2013-01-25 |
인트렉손 코포레이션 |
치료적 단백질을 조건부로 발현하는 벡터，상기 벡터를 포함하는 숙주 세포 및 이의 용도
|
|
US8828944B2
(en)
|
2010-04-22 |
2014-09-09 |
Institut Gustave Roussy |
Compounds and uses thereof to induce an immunogenic cancer cell death in a subject
|
|
US9527912B2
(en)
*
|
2010-05-17 |
2016-12-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Prevention of immunological rejection of transplanted stem cells by leukocyte costimulatory molecule blockade
|
|
AU2011255463A1
(en)
*
|
2010-05-21 |
2012-11-01 |
University Of Miami |
Cancer treatment
|
|
US9234042B2
(en)
*
|
2010-10-18 |
2016-01-12 |
Delphi Genetics Sa |
Method for producing antibody using “naked” expression vector expressing type II transmembrane fusion protein
|
|
CN102462841A
(zh)
*
|
2010-11-09 |
2012-05-23 |
中国科学院微生物研究所 |
一种促进gp96蛋白的免疫活性的方法及其应用
|
|
WO2012116142A2
(en)
*
|
2011-02-23 |
2012-08-30 |
University Of Miami |
Combined cell based gp96-ig-siv/hiv, recombinant gp120 protein vaccination for protection from siv/hiv
|
|
CA2874998A1
(en)
|
2011-05-27 |
2012-12-06 |
Cytocure Llc |
Methods, compositions, and kits for the treatment of cancer
|
|
KR101749195B1
(ko)
*
|
2011-12-12 |
2017-06-20 |
셀 메디카 리미티드 |
T 세포들을 증식시키는 방법
|
|
EP3466443B1
(en)
*
|
2012-02-14 |
2020-12-16 |
Boehringer Ingelheim Animal Health USA Inc. |
Recombinant poxviral vectors expressing both rabies and ox40 proteins, and vaccines made therefrom
|
|
EP3508215A3
(en)
*
|
2012-12-03 |
2019-10-02 |
Bristol-Myers Squibb Company |
Enhancing anti-cancer activity of immunomodulatory fc fusion proteins
|
|
WO2014106602A1
(en)
*
|
2013-01-02 |
2014-07-10 |
Glenmark Pharmaceuticals S.A. |
Antibodies that bind to tl1a and their uses
|
|
US20140193410A1
(en)
*
|
2013-01-09 |
2014-07-10 |
University Of Miami |
Compositions and Methods for the Regulation of T Regulatory Cells Using TL1A-Ig Fusion Protein
|
|
WO2014121099A1
(en)
*
|
2013-01-31 |
2014-08-07 |
Thomas Jefferson University |
Agonist fusion protein for cd40 ox40 and uses thereof
|
|
EP2970490A4
(en)
|
2013-03-15 |
2017-04-26 |
Novelogics Biotechnology, Inc. |
Antibodies to mica and micb proteins
|
|
WO2014140884A2
(en)
|
2013-03-15 |
2014-09-18 |
Novelogics Biotechnology, Inc. |
Methods and devices for removal of immunosuppressive ligands
|
|
US10196435B2
(en)
*
|
2013-11-18 |
2019-02-05 |
University Of Southern California |
OX40L fusion protein for the immunotherapy of tumors of veterinary animals
|
|
CN106029889A
(zh)
*
|
2013-11-22 |
2016-10-12 |
德那翠丝有限公司 |
表达免疫细胞刺激受体激动剂的腺病毒
|
|
KR20230076867A
(ko)
*
|
2013-12-20 |
2023-05-31 |
더 브로드 인스티튜트, 인코퍼레이티드 |
신생항원 백신과의 병용 요법
|
|
WO2015131176A1
(en)
*
|
2014-02-28 |
2015-09-03 |
Podack Eckhard R |
Compositions, methods, and kits for treatment of cancer
|
|
ES2774381T3
(es)
*
|
2014-04-03 |
2020-07-20 |
Univ Res Inst Inc Augusta |
Métodos para mejorar la eficacia de la respuesta inmune dirigida a tumores
|
|
EP3148573A4
(en)
*
|
2014-05-29 |
2017-11-15 |
Medimmune, LLC |
Ox40l fusion proteins and uses thereof
|
|
MA41414A
(fr)
*
|
2015-01-28 |
2017-12-05 |
Centre Nat Rech Scient |
Protéines de liaison agonistes d' icos
|
|
MA41460A
(fr)
*
|
2015-02-03 |
2017-12-12 |
Oncomed Pharm Inc |
Agents de liaison à la tnfrsf et leurs utilisations
|
|
SG11201705844SA
(en)
*
|
2015-02-06 |
2017-08-30 |
Heat Biologics Inc |
Vector co-expressing vaccine and costimulatory molecules
|
|
SG11201708804WA
(en)
*
|
2015-05-07 |
2017-11-29 |
Agenus Inc |
Anti-ox40 antibodies and methods of use thereof
|
|
CN109219620B
(zh)
*
|
2016-06-09 |
2023-01-31 |
派立卡恩治疗公司 |
抗-tnfrsf25抗体
|
|
CA3058938A1
(en)
*
|
2017-04-04 |
2018-10-11 |
Heat Biologics, Inc. |
Intratumoral vaccination
|
|
WO2019104327A1
(en)
*
|
2017-11-27 |
2019-05-31 |
Heat Biologics, Inc. |
Gp96-based cancer therapy
|
|
CA3113454A1
(en)
*
|
2018-10-01 |
2020-04-09 |
Heat Biologics, Inc. |
Combination cell-based therapies
|
|
US20220289838A1
(en)
*
|
2019-08-19 |
2022-09-15 |
Nantong Yichen Biopharma. Co. Ltd. |
Immunocytokine, Preparation for the Same, and Uses Thereof
|
|
WO2021178416A1
(en)
*
|
2020-03-02 |
2021-09-10 |
Heat Biologics, Inc. |
Immune-mediated coronavirus treatments
|